[The future application of adoptive immunotherapy in treatment of lung cancer].
Li
P S
PS
D005544:Forecasting; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000639:trends*; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation; D008175:Lung Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins